Tonix Pharmaceuticals Holding Corp

+0.01 (+2.35%)
: $0.61 0.00 (-0.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.91M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.5 Million
Adjusted EPS-$7.89
See more estimates
10-Day MA$0.69
50-Day MA$3.14
200-Day MA$9.91
See more pivots

Tonix Pharmaceuticals Holding Corp Stock, NASDAQ:TNXP

26 Main Street, Suite 101, Chatham, New Jersey 07928
United States of America
Phone: +1.862.799.8599
Number of Employees: 103


Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.